Acta Scientific Paediatrics (ISSN: 2581-883X)

Review Article Volume 4 Issue 3

Pediatric Ocular Conditions-Guidelines for Treatment during COVID 19 Pandemic

Meenakshi Wadhwani1* and Kulbhushan Gangwani2

1MS Ophthalmology, Assistant Professor, Chacha Nehru Bal Chikitsalya, New Delhi, India
2Consultant Pediatrician, RB Medical Centre, Delhi, India

*Corresponding Author: Meenakshi Wadhwani, Assistant Professor and Officer in Charge Ophthalmology, Chacha Nehru Bal Chikitsalya, New Delhi, India.

Received: October 15, 2020; Published: February 11, 2021



  Covid-19 caused by SARS COV-2, is associated with neurological and ophthalmological manifestations. It is one the largest global pandemic affecting over 3 million people in 213 countries worldwide. It has led to a death toll of > 200 thousand people in a short period of 4 months as per WHO on May 1st 2020. India has reported over 33,000 cases with > 1000 deaths [1,2].

Keywords: Covid-19; SARS COV-2; Pediatric Ocular Conditions



  1. Mungmungpuntipantip R and Wiwanitkit V. “Ocular manifestation, eye protection, and COVID-19”. Graefe's Archive for Clinical and Experimental Ophthalmology (2020).
  2. Li JO., et al. “Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear”. British Journal of Ophthalmology 104 (2020): 297-298.
  3. Huang C., et al. “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China”. Lancet 395 (2020): 497-506.
  4. Wu P., et al. “Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China”. JAMA Ophthalmology (2020).
  5. Xu Y., et al. “Characteristics of pediatric SARS‑CoV‑2 infection and potential evidence for persistent fecal viral shedding”. Nature Medicine 26 (2020): 502‑505.
  6. Esposito S and Principi N. “To mask or not to mask children to overcome COVID‑19”. European Journal of Pediatrics 9 (2020): 1‑4.
  7. Honavar SG. “Navigating the new normal in ophthalmology”. Indian Journal of Ophthalmology 68 (2020): 957-958.
  8. Waikar S and Oli A. “COVID-19: Ophthalmic prophylactic and therapeutic measures”. Indian Journal of Ophthalmology 68 (2020): 1223-1224.
  9. Lim LW., et al. “Sustainable practice of ophthalmology during COVID‑19: Challenges and solutions”. Graefe's Archive for Clinical and Experimental Ophthalmology 21 (2020): 1‑10.
  10. Saxena R., et al. “Pediatric ophthalmology, strabismus and neuro-ophthalmology practice in the COVID-19 era: All India Ophthalmological Society guidelines”. Indian Journal of Ophthalmology 68 (2020): 1300-1305.
  11. Das AV and Narayanan R. “Demographics and clinical presentation of patients with ocular disorders during the COVID-19 lockdown in India: A report”. Indian Journal of Ophthalmology 68 (2020): 1393-1399.
  12. Romano MR., et al. “Facing COVID‑19 in ophthalmology department”. Current Eye Research 45 (2020): 653‑658.


Citation: Meenakshi Wadhwani and Kulbhushan Gangwani. “Pediatric Ocular Conditions-Guidelines for Treatment during COVID 19 Pandemic". Acta Scientific Paediatrics 4.3 (2021): 28-30.


Acceptance rate33%
Acceptance to publication20-30 days
Impact Factor1.197

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 20, 2023.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue".
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US